Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, May 29, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include a Gilead Sciences’ and Arcus Biosciences’ collaboration agreement on cancer immunotherapies for $175 million and Novavax, Inc.’s acquisition of Praha Vaccines for $167 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition... Read More »
Health Care M&A Deals, May 22, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include Omada Health’s acquisitions of Physera, Inc. for $37 million and Induction Healthcare Group PLC ‘s purchase of Zesty $15.56 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the... Read More »
Health Care M&A Deals, May 15, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include Primary Health Properties acquisition of a portfolio of medical office buildings for $66.6 million and The DNA Company’s purchase of My Pain Sensei for $30 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and... Read More »
April Healthcare M&A Took a Hit
Correlation doesn’t prove causation, but the evidence is hard to ignore. April healthcare M&A took a hit as COVID-19 forced businesses to close, workers to stay home, and providers to divert all their attention toward treating the flood of infected patients. Compared with last March, April saw a 21% drop in activity and a 34% drop compared with April 2019. The decline was even more pronounced among the sectors. Long-Term Care, an unfortunately hard-hit industry from the pandemic, suffered a profound drop of 40%. Our colleagues on the senior care side used the word “anemic” to describe the second half of April for Long-Term Care transactions. Half of the month’s deals closed in the... Read More »
Health Care M&A Deals, May 8, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. This week’s top deals include Portola Pharmaceuticals, Inc.’s acquisition of Alexion Pharmaceuticals, Inc. for $1.6 billion and Menarini Group’s purchase of Stemline Therapeutics Inc. for $629.7 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
